N-Methyl-D-aspartic acid
N-Methyl-D-aspartic acid[edit | edit source]
N-Methyl-D-aspartic acid (NMDA) is a synthetic amino acid derivative that acts as a specific agonist at the NMDA receptor, mimicking the action of the neurotransmitter glutamate on this receptor. NMDA is crucial in the study of neurophysiology and neuropharmacology due to its role in synaptic plasticity, a cellular mechanism for learning and memory.
Structure and Properties[edit | edit source]
NMDA is a derivative of the amino acid aspartic acid, with a methyl group attached to the nitrogen atom. This modification allows NMDA to selectively bind to and activate NMDA receptors, which are a subtype of glutamate receptors. The chemical structure of NMDA is C5H9NO4.
NMDA Receptor[edit | edit source]
The NMDA receptor is a type of ionotropic receptor that is activated by the neurotransmitters glutamate and glycine. It is a crucial component in the central nervous system and plays a key role in synaptic plasticity, which is essential for learning and memory. NMDA receptors are unique in that they require both ligand binding and membrane depolarization to open their ion channel, allowing calcium (Ca2+), sodium (Na+), and potassium (K+) ions to flow through.
Function in the Nervous System[edit | edit source]
NMDA receptors are involved in various physiological processes, including long-term potentiation (LTP), which is a long-lasting enhancement in signal transmission between two neurons that results from stimulating them simultaneously. LTP is considered one of the major cellular mechanisms that underlie learning and memory.
Clinical Significance[edit | edit source]
Dysfunction of NMDA receptors is implicated in several neurological disorders, including Alzheimer's disease, schizophrenia, and epilepsy. Drugs that modulate NMDA receptor activity are being investigated for their potential therapeutic effects in these conditions. For example, memantine is an NMDA receptor antagonist used in the treatment of moderate to severe Alzheimer's disease.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
